Frontier Biotechnologies Inc. (SHA:688221)

Frontier Biotechnologies Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,821	3,656	3,716	6,465	6,688	6,925
Market Cap Growth	80.90%	-1.61%	-42.53%	-3.33%	-3.43%	-
Enterprise Value	5,427	3,442	3,055	5,391	5,318	6,738
Last Close Price	15.54	9.76	9.92	17.26	18.59	19.25
PS Ratio	42.47	28.24	32.52	76.29	165.12	148.54
PB Ratio	5.58	3.20	2.77	3.87	3.65	3.24
P/TBV Ratio	6.43	3.69	3.34	4.57	4.26	3.74
EV/Sales Ratio	39.60	26.59	26.74	63.61	131.30	144.52
Debt / Equity Ratio	0.32	0.36	0.28	0.17	0.16	0.02
Asset Turnover	0.07	0.07	0.05	0.03	0.02	0.03
Inventory Turnover	1.53	1.91	1.42	1.47	1.91	2.58
Quick Ratio	2.65	2.81	2.65	4.64	3.76	16.07
Current Ratio	2.88	3.09	2.90	5.07	3.95	16.40
Return on Equity (ROE)	-12.42%	-16.21%	-21.83%	-20.38%	-13.36%	-17.17%
Return on Assets (ROA)	-8.44%	-8.76%	-9.45%	-10.08%	-7.95%	-8.88%
Return on Capital (ROIC)	-10.43%	-10.58%	-11.71%	-12.23%	-9.35%	-10.90%
Earnings Yield	-2.38%	-5.51%	-8.85%	-5.52%	-3.89%	-3.33%
FCF Yield	-3.59%	-5.23%	-10.67%	-6.64%	-8.53%	-5.15%
Buyback Yield / Dilution	-0.35%	0.24%	-2.69%	-0.79%	-25.23%	-9.40%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.